Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cognitive Decline Due to Alzheimer Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02322021
What this trial is testing

Dose-Finding Study To Evaluate Safety, Tolerability, and Efficacy of E2609 in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (Prodromal Alzheimer's Disease) and Mild to Moderate Dementia Due to Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia, Alzheimer Type
Eisai Inc. 70
Testing effectiveness (Phase 2)Study completedNCT05104463
What this trial is testing

CST-2032 and CST-107 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's or Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentDementia
CuraSen Therapeutics, Inc. 64
Testing effectiveness (Phase 2)Ended earlyNCT03352557
What this trial is testing

Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Biogen 654
Early research (Phase 1)Study completedNCT01837641
What this trial is testing

LY3002813 in Participants With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 63
Large-scale testing (Phase 3)Study completedNCT05542953
What this trial is testing

[18F]APN-1607 PET in Subjects With AD Compared to HC

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment Due to Alzheimer's DiseaseHealthy Volunteers
APRINOIA Therapeutics 230
Early research (Phase 1)Study completedNCT03019536
What this trial is testing

LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 22
Early research (Phase 1)Study completedNCT02094729
What this trial is testing

A Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamic Response of Repeated Intravenous Infusions of BAN2401 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eisai Co., Ltd. 26
Not applicableLooking for participantsNCT06792877
What this trial is testing

Mindfulness for Cognition in Early-stage Alzheimer's Disease

Who this might be right for
Mild Cognitive Impairment (MCI)Mild Cognitive Impairment (MCI) Due to Alzheimer's DiseaseTBI (Traumatic Brain Injury)+3 more
VA Boston Healthcare System 100
Not applicableLooking for participantsNCT07768579
What this trial is testing

The Effect of Sequential Therapy on Alzheimer's Disease

Who this might be right for
Mild Cognitive Impairment Due to Alzheimer DiseaseAlzheimer Disease
Dongzhimen Hospital, Beijing 600
Testing effectiveness (Phase 2)Study completedNCT05004688
What this trial is testing

A Trial to Evaluate the Effects of BCG in Adults With MCI and Mild-to-Moderate AD

Who this might be right for
Mild Cognitive ImpairmentMild DementiaModerate Dementia+1 more
Steven E Arnold, MD 15
Testing effectiveness (Phase 2)Study completedNCT04191486
What this trial is testing

Efficacy and Safety of T-817MA in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD

Who this might be right for
Mild Cognitive Impairment
FUJIFILM Toyama Chemical Co., Ltd. 221
Not applicableActive Not RecruitingNCT02951598
What this trial is testing

Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
Eli Lilly and Company 1,400
Testing effectiveness (Phase 2)Ended earlyNCT03639987
What this trial is testing

Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging Abnormalities

Who this might be right for
Cognitive DysfunctionAlzheimer's Disease
Biogen 52
Early research (Phase 1)Study completedNCT02754830
What this trial is testing

LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 72
Testing effectiveness (Phase 2)Study completedNCT05619692
What this trial is testing

Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)

Who this might be right for
Mild Cognitive ImpairmentMild DementiaAlzheimer's Disease
Supernus Pharmaceuticals, Inc. 174
Testing effectiveness (Phase 2)Active Not RecruitingNCT05399888
What this trial is testing

Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age

Who this might be right for
Mild Cognitive Impairment Due to Alzheimer's DiseaseAlzheimer's Disease Dementia
Biogen 416
Early research (Phase 1)Study completedNCT05681819
What this trial is testing

SHR-1707 With Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Shanghai Hengrui Pharmaceutical Co., Ltd. 33
Early research (Phase 1)Ended earlyNCT06247345
What this trial is testing

A Phase Ia/Ib, First-in-human (FIH) Study for Safety, Tolerability, Pharmacokinetics (PK), and Clinical Activity Evaluation of ADEL-Y01

Who this might be right for
Alzheimer Disease
Alzheimer's Disease Expert Lab (ADEL), Inc. 42
Early research (Phase 1)Ended earlyNCT02614131
What this trial is testing

LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)

Who this might be right for
HealthyAlzheimer's DiseaseMild Cognitive Impairment
Eli Lilly and Company 50
Not applicableLooking for participantsNCT06058234
What this trial is testing

Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study

Who this might be right for
Mild Alzheimer's DiseaseMild Cognitive Impairment (MCI) Due to Alzheimer's Disease
Centers for Medicare and Medicaid Services/ Coverage and Analysis Group 8,680
Next Page